US Stock MarketDetailed Quotes

SLN Silence Therapeutics

Watchlist
  • 8.290
  • +0.610+7.94%
Trading Nov 22 11:10 ET
391.41MMarket Cap-4899P/E (TTM)

Silence Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-59.19%1.14M
-93.43%598K
9.07%12.41M
44.99%25.38M
-55.95%2.1M
-17.00%2.8M
149.90%9.1M
98.78%11.37M
40.97%17.5M
39.57%4.77M
Operating revenue
-59.19%1.14M
-93.43%598K
9.07%12.41M
44.99%25.38M
-55.95%2.1M
-17.00%2.8M
149.90%9.1M
98.78%11.37M
40.97%17.5M
39.57%4.77M
Cost of revenue
72.62%2.77M
-6.82%2.64M
-51.19%2.21M
-5.17%10.32M
-65.12%1.35M
-32.87%1.61M
20.37%2.83M
99.30%4.53M
45.92%10.88M
88.98%3.86M
Gross profit
-237.03%-1.63M
-132.52%-2.04M
49.02%10.19M
127.41%15.06M
-16.89%753K
21.90%1.19M
385.90%6.27M
98.43%6.84M
33.51%6.62M
-33.97%906K
Operating expense
50.50%20.91M
-8.16%16.28M
-24.44%14.35M
17.11%64.66M
18.41%14.05M
-4.85%13.89M
15.28%17.73M
42.04%18.99M
8.75%55.21M
-6.08%11.87M
Selling and administrative expenses
12.99%5.6M
3.38%5.29M
-19.84%5.17M
5.24%20.64M
18.66%4.12M
-14.95%4.96M
12.47%5.12M
11.86%6.45M
-1.99%19.61M
-35.91%3.47M
-General and administrative expense
12.99%5.6M
3.38%5.29M
-19.84%5.17M
5.24%20.64M
18.66%4.12M
-14.95%4.96M
12.47%5.12M
11.86%6.45M
-1.99%19.61M
-35.91%3.47M
Research and development costs
71.31%15.31M
-12.84%11M
-26.80%9.18M
23.65%44.03M
18.31%9.94M
1.86%8.93M
16.46%12.62M
64.92%12.54M
15.73%35.61M
16.27%8.4M
Operating profit
-77.47%-22.54M
-59.93%-18.32M
65.79%-4.16M
-2.08%-49.6M
-21.33%-13.3M
6.77%-12.7M
18.68%-11.46M
-22.45%-12.15M
-6.07%-48.59M
2.68%-10.96M
Net non-operating interest income expense
-473.95%-7.62M
259.49%882K
250.95%791K
688.83%1.41M
108.78%451K
-52.55%2.04M
-182.66%-553K
-249.71%-524K
8,850.00%179K
-6,518.75%-5.14M
Non-operating interest income
-52.05%981K
213.24%1.07M
139.29%804K
539.82%1.45M
107.58%388K
-52.74%2.05M
-49.18%340K
-4.00%336K
2,160.00%226K
-256,200.00%-5.12M
Non-operating interest expense
107,425.00%8.6M
-79.51%183K
-98.49%13K
-27.66%34K
-584.62%-63K
-76.47%8K
--893K
--860K
487.50%47K
116.67%13K
Other net income (expense)
-302.49%-2.12M
2,477.27%1.05M
Gain on sale of security
----
----
----
-302.49%-2.12M
----
----
----
----
2,477.27%1.05M
----
Income before tax
-182.88%-30.16M
-45.22%-17.44M
73.45%-3.37M
-6.21%-50.31M
0.56%-14.97M
-14.31%-10.66M
10.51%-12.01M
-32.40%-12.67M
-3.30%-47.37M
-34.05%-15.05M
Income tax
-30.49%-3.15M
-16.78%-1.88M
39.69%-1.49M
-2.38%-7.04M
56.95%-554K
-8.46%-2.41M
-8.64%-1.61M
-30.77%-2.47M
-6.72%-6.88M
28.22%-1.29M
Net income
-227.42%-27.01M
-49.62%-15.56M
81.62%-1.88M
-6.86%-43.27M
-4.72%-14.41M
-16.15%-8.25M
12.88%-10.4M
-32.80%-10.2M
-2.74%-40.49M
-45.89%-13.76M
Net income continuous Operations
-227.42%-27.01M
-49.62%-15.56M
81.62%-1.88M
-6.86%-43.27M
-4.72%-14.41M
-16.15%-8.25M
12.88%-10.4M
-32.80%-10.2M
-2.74%-40.49M
-45.89%-13.76M
Minority interest income
Net income attributable to the parent company
-227.42%-27.01M
-49.62%-15.56M
81.62%-1.88M
-6.86%-43.27M
-4.72%-14.41M
-16.15%-8.25M
12.88%-10.4M
-32.80%-10.2M
-2.74%-40.49M
-45.89%-13.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-227.42%-27.01M
-49.62%-15.56M
81.62%-1.88M
-6.86%-43.27M
-4.72%-14.41M
-16.15%-8.25M
12.88%-10.4M
-32.80%-10.2M
-2.74%-40.49M
-45.89%-13.76M
Basic earnings per share
-158.11%-0.573
-15.63%-0.333
85.26%-0.042
7.16%-1.167
4.58%-0.375
-2.78%-0.222
27.82%-0.288
-10.47%-0.285
5.42%-1.257
-24.76%-0.393
Diluted earnings per share
-158.11%-0.573
-15.63%-0.333
85.26%-0.042
7.16%-1.167
4.58%-0.375
-2.78%-0.222
27.82%-0.288
-10.47%-0.285
5.42%-1.257
-24.76%-0.393
Dividend per share
Currency Unit
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -59.19%1.14M-93.43%598K9.07%12.41M44.99%25.38M-55.95%2.1M-17.00%2.8M149.90%9.1M98.78%11.37M40.97%17.5M39.57%4.77M
Operating revenue -59.19%1.14M-93.43%598K9.07%12.41M44.99%25.38M-55.95%2.1M-17.00%2.8M149.90%9.1M98.78%11.37M40.97%17.5M39.57%4.77M
Cost of revenue 72.62%2.77M-6.82%2.64M-51.19%2.21M-5.17%10.32M-65.12%1.35M-32.87%1.61M20.37%2.83M99.30%4.53M45.92%10.88M88.98%3.86M
Gross profit -237.03%-1.63M-132.52%-2.04M49.02%10.19M127.41%15.06M-16.89%753K21.90%1.19M385.90%6.27M98.43%6.84M33.51%6.62M-33.97%906K
Operating expense 50.50%20.91M-8.16%16.28M-24.44%14.35M17.11%64.66M18.41%14.05M-4.85%13.89M15.28%17.73M42.04%18.99M8.75%55.21M-6.08%11.87M
Selling and administrative expenses 12.99%5.6M3.38%5.29M-19.84%5.17M5.24%20.64M18.66%4.12M-14.95%4.96M12.47%5.12M11.86%6.45M-1.99%19.61M-35.91%3.47M
-General and administrative expense 12.99%5.6M3.38%5.29M-19.84%5.17M5.24%20.64M18.66%4.12M-14.95%4.96M12.47%5.12M11.86%6.45M-1.99%19.61M-35.91%3.47M
Research and development costs 71.31%15.31M-12.84%11M-26.80%9.18M23.65%44.03M18.31%9.94M1.86%8.93M16.46%12.62M64.92%12.54M15.73%35.61M16.27%8.4M
Operating profit -77.47%-22.54M-59.93%-18.32M65.79%-4.16M-2.08%-49.6M-21.33%-13.3M6.77%-12.7M18.68%-11.46M-22.45%-12.15M-6.07%-48.59M2.68%-10.96M
Net non-operating interest income expense -473.95%-7.62M259.49%882K250.95%791K688.83%1.41M108.78%451K-52.55%2.04M-182.66%-553K-249.71%-524K8,850.00%179K-6,518.75%-5.14M
Non-operating interest income -52.05%981K213.24%1.07M139.29%804K539.82%1.45M107.58%388K-52.74%2.05M-49.18%340K-4.00%336K2,160.00%226K-256,200.00%-5.12M
Non-operating interest expense 107,425.00%8.6M-79.51%183K-98.49%13K-27.66%34K-584.62%-63K-76.47%8K--893K--860K487.50%47K116.67%13K
Other net income (expense) -302.49%-2.12M2,477.27%1.05M
Gain on sale of security -------------302.49%-2.12M----------------2,477.27%1.05M----
Income before tax -182.88%-30.16M-45.22%-17.44M73.45%-3.37M-6.21%-50.31M0.56%-14.97M-14.31%-10.66M10.51%-12.01M-32.40%-12.67M-3.30%-47.37M-34.05%-15.05M
Income tax -30.49%-3.15M-16.78%-1.88M39.69%-1.49M-2.38%-7.04M56.95%-554K-8.46%-2.41M-8.64%-1.61M-30.77%-2.47M-6.72%-6.88M28.22%-1.29M
Net income -227.42%-27.01M-49.62%-15.56M81.62%-1.88M-6.86%-43.27M-4.72%-14.41M-16.15%-8.25M12.88%-10.4M-32.80%-10.2M-2.74%-40.49M-45.89%-13.76M
Net income continuous Operations -227.42%-27.01M-49.62%-15.56M81.62%-1.88M-6.86%-43.27M-4.72%-14.41M-16.15%-8.25M12.88%-10.4M-32.80%-10.2M-2.74%-40.49M-45.89%-13.76M
Minority interest income
Net income attributable to the parent company -227.42%-27.01M-49.62%-15.56M81.62%-1.88M-6.86%-43.27M-4.72%-14.41M-16.15%-8.25M12.88%-10.4M-32.80%-10.2M-2.74%-40.49M-45.89%-13.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -227.42%-27.01M-49.62%-15.56M81.62%-1.88M-6.86%-43.27M-4.72%-14.41M-16.15%-8.25M12.88%-10.4M-32.80%-10.2M-2.74%-40.49M-45.89%-13.76M
Basic earnings per share -158.11%-0.573-15.63%-0.33385.26%-0.0427.16%-1.1674.58%-0.375-2.78%-0.22227.82%-0.288-10.47%-0.2855.42%-1.257-24.76%-0.393
Diluted earnings per share -158.11%-0.573-15.63%-0.33385.26%-0.0427.16%-1.1674.58%-0.375-2.78%-0.22227.82%-0.288-10.47%-0.2855.42%-1.257-24.76%-0.393
Dividend per share
Currency Unit GBPGBPGBPGBPGBPGBPGBPGBPGBPGBP
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-1.02%